Document is current
Any future updates will be listed below
-
Authors
Brady, Samuel W. https://orcid.org/0000-0001-5518-7800
Liu, Yanling
Ma, Xiaotu
Gout, Alexander M.
Hagiwara, Kohei
Zhou, Xin
Wang, Jian
Macias, Michael https://orcid.org/0000-0002-5933-8095
Chen, Xiaolong https://orcid.org/0000-0001-8283-0582
Easton, John
Mulder, Heather L. https://orcid.org/0000-0003-2024-9498
Rusch, Michael https://orcid.org/0000-0002-5363-1848
Wang, Lu https://orcid.org/0000-0002-0073-0666
Nakitandwe, Joy
Lei, Shaohua
Davis, Eric M.
Naranjo, Arlene
Cheng, Cheng
Maris, John M.
Downing, James R.
Cheung, Nai-Kong V. https://orcid.org/0000-0001-6323-5171
Hogarty, Michael D. https://orcid.org/0000-0002-9221-4852
Dyer, Michael A. https://orcid.org/0000-0003-4027-4850
Zhang, Jinghui https://orcid.org/0000-0003-3350-9682
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA021765, R35 CA220500, NCI U10 CA180899)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | Center for Information Technology (NCI R01 CA216391-01A1)
- License Information
-
More Information
Article History
Received: 2 March 2020
Accepted: 27 August 2020
First Online: 14 October 2020
Competing interests
: N.V.C. reports receiving commercial research grants from Y-mabs Therapeutics and Abpro-Labs Inc., holding ownership interest/equity in Y-Mabs Therapeutics Inc., holding ownership interest/equity in Abpro-Labs, and owning stock options in Eureka Therapeutics. N.V.C. is the inventor of issued and pending patents filed by Memorial Sloan-Kettering Cancer Center (MSK), including those licensed by MSK to Ymabs Therapeutics, Biotec Pharmacon, and Abpro-labs. Both MSK and N.V.C. have financial interest in Y-mabs. N.V.C. is an advisory board member for Abpro-Labs and Eureka Therapeutics. The remaining authors declare no competing interests.
